Crossmark

Treatment of a high cardiovascular risk patient with McArdle's disease with PCSK9 inhibitors

Crossref DOI link: https://doi.org/10.1016/j.artere.2019.02.004

Published Print: 2019-03

Update policy: https://doi.org/10.1016/elsevier_cm_policy

Authors

Marco-Benedí, Victoria

Jarauta, Estíbaliz

Pérez-Calahorra, Sofía

Bea, Ana M.

Civeira, Fernando
License Information

Text and Data Mining valid from 2019-03-01
More Information

This article is maintained by: Elsevier

Article Title: Treatment of a high cardiovascular risk patient with McArdle's disease with PCSK9 inhibitors

Journal Title: Clínica e Investigación en Arteriosclerosis (English Edition)

CrossRef DOI link to publisher maintained version: https://doi.org/10.1016/j.artere.2019.02.004

CrossRef DOI link to the associated document: https://doi.org/10.1016/j.arteri.2018.11.005

Content Type: article

Copyright: © 2019 Published by Elsevier España, S.L.U. on behalf of Sociedad Española de Arteriosclerosis.